• Profile
Close

Tumor volume as predictor of pathologic complete response following neoadjuvant chemoradiation in locally advanced rectal cancer

American Journal of Clinical Oncology Sep 02, 2021

Lutsyk M, Awawda M, Gourevich K, et al. - Findings suggest a possible value of gross tumor volume (GTV) for predicting complete pathologic response (pCR) in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.

  • Enrolled were patients diagnosed with stage IIA to IIIC rectal adenocarcinoma, who received treatment with neoadjuvant chemoradiation.

  • Six to 8 weeks after completion of treatment, operation, either low anterior or abdominoperineal resection was performed.

  • pCR was achieved in 23.5% of the patients.

  • The only significant predictive factor to detect pCR was GTV at the volume of < 39.5 cm3 by logistic regression model and by Bayesian independent test.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay